Quickly Spot Consensus Among the World's Best Equity Analysts
| Name | Upside % |
Analysts bullish % |
|
|---|---|---|---|
|
1,428%
upside
4 price targets
|
0
%
|
|
|
|
1,300%
upside
3 price targets
|
0
%
|
|
|
|
922%
upside
3 price targets
|
0
%
|
|
|
|
ATYR
4
aTyr Pharma
ATYR
$82.5M
|
672%
upside
3 price targets
|
0
%
|
|
|
647%
upside
3 price targets
|
0
%
|
|
|
|
631%
upside
4 price targets
|
0
%
|
|
|
|
516%
upside
4 price targets
|
0
%
|
|
|
|
461%
upside
3 price targets
|
0
%
|
|
|
|
461%
upside
6 price targets
|
0
%
|
|
|
|
419%
upside
3 price targets
|
0
%
|
|
|
11
Humacyte
HUMA
$298M
|
416%
upside
5 price targets
|
0
%
|
|
|
415%
upside
3 price targets
|
0
%
|
|
|
|
411%
upside
4 price targets
|
0
%
|
|
|
|
385%
upside
5 price targets
|
0
%
|
|
|
|
385%
upside
3 price targets
|
0
%
|
|
|
|
381%
upside
3 price targets
|
0
%
|
|
|
|
363%
upside
3 price targets
|
0
%
|
|
|
|
357%
upside
3 price targets
|
0
%
|
|
|
|
348%
upside
3 price targets
|
0
%
|
|
|
|
347%
upside
3 price targets
|
0
%
|
|
|
|
342%
upside
3 price targets
|
0
%
|
|
|
|
317%
upside
3 price targets
|
0
%
|
|
|
|
317%
upside
3 price targets
|
0
%
|
|
|
|
301%
upside
4 price targets
|
0
%
|
|
|
|
284%
upside
3 price targets
|
0
%
|
|